ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% Trademark

Trademark Overview

On Friday, March 29, 2019, a trademark application was filed for ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% with the United States Patent and Trademark Office. The USPTO has given the ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% trademark a serial number of 88362786. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 14, 2022. This trademark is owned by Aerie Pharmaceuticals, Inc.. The ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of glaucoma and ocular hypertension
rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%

General Information

Serial Number88362786
Word MarkROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%
Filing DateFriday, March 29, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 11, 2019

Trademark Statements

Description of MarkThe mark consists of the word "ROCKLATAN" in lower case block letters in between four curved bands, which create the impression of parentheses. Two of the curved bands are depicted before the term "ROCKLATAN " and two curved bands are depicted after the term "ROCKLATAN" with the words "(NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%" beneath the word "ROCKLATAN".
Goods and ServicesPharmaceutical preparations for the treatment of glaucoma and ocular hypertension
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"(NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAerie Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921

Trademark Events

Event DateEvent Description
Monday, March 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 6, 2021SOU EXTENSION 4 GRANTED
Friday, August 6, 2021SOU EXTENSION 4 FILED
Friday, August 6, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 5, 2021SOU EXTENSION 3 GRANTED
Friday, February 5, 2021SOU EXTENSION 3 FILED
Friday, February 5, 2021SOU TEAS EXTENSION RECEIVED
Friday, August 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 5, 2020SOU EXTENSION 2 GRANTED
Wednesday, August 5, 2020SOU EXTENSION 2 FILED
Wednesday, August 5, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, April 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 7, 2020SOU EXTENSION 1 GRANTED
Thursday, February 6, 2020SOU EXTENSION 1 FILED
Tuesday, April 7, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 17, 2020NOTICE OF REVIVAL - E-MAILED
Monday, March 16, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, March 16, 2020PETITION TO REVIVE-GRANTED
Monday, March 16, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, March 9, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 9, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 6, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 11, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 22, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 9, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 6, 2019ASSIGNED TO LIE
Monday, April 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 19, 2019EXAMINER'S AMENDMENT ENTERED
Friday, April 19, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 19, 2019EXAMINERS AMENDMENT E-MAILED
Friday, April 19, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, April 19, 2019ASSIGNED TO EXAMINER
Wednesday, April 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 2, 2019NEW APPLICATION ENTERED

Related Keywords

solution ophthalmic latanoprost netarsudil rocklatan ocular hypertension glaucoma treatment preparations pharmaceutical